Literature DB >> 16148727

Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.

Miguel A Gonzalez-Gay1, Sonia Barros, Maria J Lopez-Diaz, Carlos Garcia-Porrua, Amalia Sanchez-Andrade, Javier Llorca.   

Abstract

Classically, patients with giant cell arteritis (GCA) present with cranial ischemic manifestations that are directly related to vascular involvement. However, a variable proportion of GCA patients may present without obvious vascular manifestations. Since a high index of suspicion of this condition in individuals over the age of 50 years is needed to prevent the development of severe complications, we have studied the different patterns of disease presentation in a series of 240 patients with biopsy-proven GCA diagnosed at the single hospital for the well-defined population of Lugo, Spain, between January 1, 1981, and June 15, 2004. During the study period, 203 (86.4%) GCA patients presented with headache. Patients with headache were found to have an abnormal temporal artery on physical examination more commonly than the other GCA patients (79.8% versus 35.1%; p < 0.001). Compared with the other GCA patients, those who presented with polymyalgia rheumatica (PMR) were younger (73.4 +/- 6.3 versus 75.6 +/- 6.9 yr; p = 0.013) and had a longer delay to diagnosis (13.4 +/- 12.2 versus 8.3 +/- 10.0 wk; p = 0.013). One hundred thirty-one (54.6%) patients presented with severe ischemic manifestations. Abnormal temporal artery on physical examination (odds ratio, 2.25) and anemia at the time of disease diagnosis (odds ratio, 0.53) were found to be the best predictors for severe ischemic manifestations of GCA. Eighteen (7.5%) patients presented without overt ischemic manifestations of GCA. Patients younger than 70 years of age at the time of diagnosis had a longer delay to diagnosis and exhibited PMR more commonly than older patients. Our observations confirm the presence of different disease patterns of clinical presentation in GCA and emphasize the importance of an abnormal temporal artery on physical examination and anemia as factors that may predict the risk of severe ischemic complications related to GCA.

Entities:  

Mesh:

Year:  2005        PMID: 16148727     DOI: 10.1097/01.md.0000180042.42156.d1

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  49 in total

Review 1.  Giant cell arteritis: epidemiology, diagnosis, and management.

Authors:  Miguel A Gonzalez-Gay; Cristina Martinez-Dubois; Mario Agudo; Orlando Pompei; Ricardo Blanco; Javier Llorca
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

2.  Vasculitis syndromes: Not losing sight is the issue in GCA management.

Authors:  Miguel A González-Gay; Vicente Rodríguez-Valverde
Journal:  Nat Rev Rheumatol       Date:  2010-08       Impact factor: 20.543

Review 3.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Giant cell arteritis: diagnosis and therapeutic management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 5.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 6.  Updates in the Diagnosis and Management of Giant Cell Arteritis.

Authors:  Surabhi Uppal; Mohanad Hadi; Sheetal Chhaya
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-08       Impact factor: 5.081

7.  Giant Cell Arteritis with Carotidynia.

Authors:  Kiyoshi Shikino; Shiho Yamashita; Masatomi Ikusaka
Journal:  J Gen Intern Med       Date:  2017-06-14       Impact factor: 5.128

8.  Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control study.

Authors:  Hubert de Boysson; Eric Liozon; Kim Heang Ly; Anael Dumont; Claire Delmas; Audrey Sultan; Achille Aouba
Journal:  Clin Rheumatol       Date:  2018-07-30       Impact factor: 2.980

9.  The process from symptom onset to rheumatology clinic in polymyalgia rheumatica.

Authors:  Ediz Dalkılıç; Ayşe Nur Tufan; Emre Hafızoğlu; Merve Hafızoğlu; Fatih Tufan; Ferhat Oksuz; Yavuz Pehlivan; Mustafa Yurtkuran
Journal:  Rheumatol Int       Date:  2014-05-11       Impact factor: 2.631

10.  Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis.

Authors:  Gil Bornstein; Iris Barshack; Nira Koren-Morag; Ilan Ben-Zvi; Nadav Furie; Chagai Grossman
Journal:  Clin Rheumatol       Date:  2018-03-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.